강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학. Staging Communication Evaluation TreatmentPrognosis Research.

Slides:



Advertisements
Similar presentations
Medical School of Oncology Highlights on NSCLC Management STAGING STRATEGIES Maria Grazia Ghi Divisione di Oncologia-Venezia Roma, 29 ottobre 2010.
Advertisements

TNM staging and prognosis Alexandru Eniu, MD, PhD Medical Oncologist Department of Breast Tumors Cancer Institute Ion Chiricuţă Cluj-Napoca, Romania.
The IASLC Lung Cancer Database Summary of Cases Contributed to Project Total cases submitted 100,869 Excluded from analyses Excluded from analyses19,854.
Small Cell Lung Cancer Clinical T-Stage, N0-N3 M0 SCLC From: Shepherd FA, Crowley J, Van Houtte P et al. The IASLC lung cancer staging project: proposals.
Jaime Palomino, MD Pulmonary, Critical Care Medicine Tulane University.
Staging. Treatment by Stage For early stage lung cancers, surgery or radiation alone For larger tumors (>4 cm) and N+, chemotherapy should be added.
AJCC Staging Moments AJCC TNM Staging 7th Edition Glottic Larynx Case #1 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York,
Credit line: Breast. In: Greene, F.L., Compton, C.C., Fritz, A.G., et al., editors. AJCC Cancer Staging Atlas. New York: Springer, 2006: ©American.
Cancer Staging. What is cancer staging? Staging describes the severity of a person’s cancer based on the extent of the original (primary) tumor and whether.
Staging and Grading of cancers By Haleigh Nelson.
Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #3 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #1 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Slides last updated: March 2015 CRC: STAGING. How colorectal cancer (CRC) is staged 1 Stage describes the extent of cancer, and is one of the most important.
Cancer Staging.
Management of Limited Stage Disease: An Overview JP AGARWAL Professor Tata Memorial Hospital Mumbai
AJCC Staging Moments AJCC TNM Staging 7th Edition Supraglottic Larynx Case #2 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New.
Anatomic sites and subsites of the vulva.
Lung Anatomic subsites of the lung. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, ©American.
Development of Lung Cancer Staging Steven M. Keller, M.D. Director Thoracic Surgery, Weiler Hospital Professor of Cardiothoracic Surgery Albert Einstein.
“Validation” of the Proposed IASLC/ITMIG Staging Revisions of Thymic Carcinomas Using Data from 287 Patients Yang Zhao; Heng Zhao Division of Thoracic.
Melanoma of the Skin Regional lymph nodes for skin sites of the head and neck. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd.
BRONCHOIAL TUMOURS.
TNM Staging: Lung TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
TNM Staging: Breast TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry
Breast Anatomic sites and subsites of the breast. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer,
ajcc TNM Staging: chapter 1, and Summary stage
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
LLG03999 TN Categorization for Rectal and Colon Cancers Based on National Survival Outcome Data 1 Mayo Clinic Cancer Center – Arizona; Scottsdale, AZ 2.
A Pictorial Guide to the Revised Staging System for Non-Small Cell Lung Cancer Through the Use of PET/CT Bruno P. Soares, MD; Katherine Zukotynski, MD;
IMAGING FINDINGS - The NSCLC stage classification is based on the TNM system: - T: extent of the primary tumor - N: extent of regional lymph node involvement.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Fallopian Tube Anatomic site of the fallopian tube. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer,
A prospective study of PET/CT in initial staging of small-cell lung cancer : comparison with CT, bone scintigraphy and bone marrow analysis B. M. Fischer1,
TNM Classification of Malignant Tumours - 8th edition Changes between the 7th and 8th editions December 2016 “We unite the cancer community to reduce.
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.
The IASLC Lung Cancer Staging Project The 8th Edition
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
AJCC/UICC 8th Edition Head and Neck Staging. “Changes in the Wind”
LL Gunderson1, JM Jessup 2, DJ Sargent 3, FL Greene 4, A Stewart 5
Clinical Outcome of Chemoradiation Therapy in Patients with Limited-Disease Small Cell Lung Cancer with Ipsilateral Pleural Effusion  Seiji Niho, MD,
The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification.
A cancer staging primer: Lung
Proposed Changes to the 7th Edition
Cancer Staging.
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer.
The Stage Classification of Lung Cancer
Lung cancer staging and TNM classification
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming.
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer  Ramón Rami-Porta, MD, FETCS,
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,
The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming.
Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report  Mitsuhiro Isaka, MD, Haruhiko Kondo,
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition  Sai-Hong.
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification.
Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD 
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for.
Multiple Primary Cancers or Multiple Metastases, That Is the Question
Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?  Chenyang Dai, MD, Yijiu Ren, MD, Dong Xie, MD, PhD,
NSCLC: Staging and TNM classification
Presentation transcript:

강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학

Staging Communication Evaluation TreatmentPrognosis Research

TNM based stage AJCC (1977) UICC (1958) Collaboration since 1982

AJCC Cancer Staging Manual editions EditionsPublicationEffective dates

References T-descriptorsJTO 2007 N-descriptorsJTO 2007 M-descriptorsJTO 2007 Stage groupingJTO 2007 ValidationJTO 2007

References SCLC (clinical staging) JTO 2007 SCLC (pathological staging) JTO 2009 Carcinoid tumorsJTO 2008 Additional prognostic factorJTO 2008 IASLC nodal mapJTO 2009

AJCC 7 th edition Based on staging project by IASLCBased on staging project by IASLC International multi-institute dataInternational multi-institute data Internal and external validationInternal and external validation

IASLC staging project 1996 IASLC workshop 1998 New staging committees 2001 Draft of data element 2005 Final submission of data

IASLC database Time Frame 1990 ~ 2000 Source of data 45 sources from 20 countries

Numbers of cases Total cases submitted100,869 Excluded from current analysis19,374 Included in analysis81,495 SCLC13,032 NSCLC68,463

Treatment modalities Surgery 42% RT 8% Chemotherapy 15% Surgery + Chemo 4% Surgery + RT 5% Chemo + RT 12% Tri- modality3 %

Distribution by continent

Validation InternalExternal By Data source Geographical regions By SEER data Literature review

Numbers analyzed T descriptors18,198 N descriptors28,371 –pN1 & pN22,876 M descriptors6,596 SCLC (clinical)8,088 SCLC (Pathologic)349 Carcinoid tumor513

T-descriptors Cutpoints of tumor size Malignant pleural effusion Separate nodules Other T2 descriptors Other T3 descriptors Other T4 descriptors

New cutpoints in size 6 th Edition7 th Edition T1≤ 3cmT1a≤ 2cm T1b≤ 3cm T2> 3cmT2a≤ 5cm T2b≤ 7cm T3> 7cm

T1 learning set (n=2,284)T2 learning set (n=2607)

Separate nodules & Malignant effusion 6 th Edition 7 th Edition Separate nodules in Same lobeT4T3 in different lobe (same lung) M1T4 in contralateral lungM1M1a Malignant pleural effusionT4M1a

N-descriptors Verification of N1, N2, & N3 Location of involved LNs Number of involved LN stations Skip metastasis Anatomical “zones”

Negative results Peripheral specific LNs Single specific LN zones Presence of skip metastasis did not had prognostic significance (except LUL with AP zone single metastasis)

Positive results? N1a single N1 zone N1b Multiple N1 zone N2a Single N2 zone N2b Multiple N2 zone

Overall disease burden, rather than anatomical location may have the most important influence on outcome

Suggestions Six Nodal zones Subdivision to 3 prognostic groups 1)N1a 2)N1b & N2a 3)N2b No change of current N-descriptors

Discrepancy in nodal maps Naruke map Naruke map (Japan Lung Cancer Society map) MD-ATS map MD-ATS map (Mountain-Dresler modification of American Thoracic Society map) vs. #1#1 & #2 #2, #3, #4R, #4L#4R, #4L #7, #10#7

M-descriptors Separate nodules –Same lobe –Same lung –Contralateral lung Malignant pleural effusion Distant metastasis –Site of interest (brain) –Single vs. multiple

Stage grouping T1a / T1b T2aT2bT3T4N0IAIBIIAIIBIIIA N1IIAIIAIIBIIIAIIIA N2IIIAIIIAIIIAIIIAIIIB N3IIIBIIIBIIIBIIIBIIIB M1a / M1b IVIVIVIVIV

AJCC the 6 th edition

AJCC the 7 th edition

Small cell lung cancer

Carcinoid tumor

Potential prognostic factors Tumor characteristics Patients characteristics Laboratory parameters Tumor biology

Potential prognostic factors

Changes in the 7 th edition Recommended for the classification of both NSCLC and SCLC and for carcinoid tumors T classification T1a (≤2cm) and T1b (>2-3cm) T2a (>3-5cm) and T2b (>5-7cm) T2 (>7cm) → T3 Multiple tumor nodules in the same lobe → T3 Multiple tumor nodules in the same lung → T4

Changes in the 7 th edition No changes in N classification But new international nodal map was proposed M classification Malignant pleural or pericardial effusion → M1a Separate tumor nodules in contralateral lung → M1a M1b designates distant metastasis MX designation has been eliminated

Limitations Lack of detailed data in each descriptors Too small numbers in specific category Different lymph node maps Biased distribution in treatment modality Effect of treatment had not been considered

New IASLC Prospective project Prospective data acquisition International multi-institute study Complete set of data Including non-anatomical prognostic factors

Timetable Data collection Follow-up 2013Data analysis Jan 2014 Submission of recommendations to UICC and AJCC Jan – July 2014 Publication in JTO 2016 Publication of 8 th edition of TNM classification by the UICC and AJCC

Future